Company Overview of Tokai Pharmaceuticals, Inc.
Key Executives for Tokai Pharmaceuticals, Inc.
|Jodie Pope Morrison||17 Relationships||Chief Executive Officer, President and Director||41|
|John S. McBride MS,MBA||10 Relationships||Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer||64|
|Philip W. Kantoff M.D.||67 Relationships||Chief Clinical Research Officer and Member of Medical Advisory Committee||--|
Tokai Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Seth L. Harrison M.D.||43 Relationships||Braeburn Pharmaceuticals, Inc.||56|
|Jodie Pope Morrison||17 Relationships||Tokai Pharmaceuticals, Inc.||41|
|Philip W. Kantoff M.D.||67 Relationships||Tokai Pharmaceuticals, Inc.||--|
|David A. Kessler M.D.||121 Relationships||TPG Growth||65|
|Stephen Buckley Jr.||24 Relationships||Enanta Pharmaceuticals, Inc.||66|
Tokai Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee Jr.||Stephen Buckley||24 Relationships||2 Executives|
|Nominating Committee M.D.||David A. Kessler||121 Relationships||2 Executives|
|Corporate Governance Committee M.D.||David A. Kessler||121 Relationships||2 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$475.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.